Development of a Robust Method for Screening PDE-5 Inhibitor Additives in Dietary Supplements Using UPLC-MS/MS

Hua Wang *

Instrumental Analysis Center, Yancheng Teachers University, Yancheng-224007, China.

*Author to whom correspondence should be addressed.


Abstract

A novel ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) method was developed to detect the illegal additive of phosphodiesterase type 5 (PDE-5) inhibitors in dietary supplements. With the optimized chromatographic program, vardenafil, sildenafil, and tadalafil were separated within 5 minutes. The MS1, MS2, and retention time of PDE-5 inhibitors were acquired simultaneously within the information dependent acquisition mass spectrometry mode. Quantification was achieved via the quantity ion current chromatogram that was extracted from the total ion current. The linear range of vardenafil and sildenafil was 0.5-48 mg/L while the range of tadalafil was 0.3-36 mg/L. The correlation coefficients of the calibration curves of three PDE-5 inhibitors were all greater than 99.9%. At three concentration levels, the RSD values of the five repeat tests were all better than 1.30%. Sildenafil was detected in one dietary supplement. The comprehensive method of this study is reliable and may be a powerful tool for routine PDE-5 inhibitor screening and determination.

Keywords: PDE-5 inhibitor, illegal additive, dietary supplements, tandem mass spectrometry


How to Cite

Wang, H. (2023). Development of a Robust Method for Screening PDE-5 Inhibitor Additives in Dietary Supplements Using UPLC-MS/MS. Asian Journal of Applied Chemistry Research, 14(4), 23–33. https://doi.org/10.9734/ajacr/2023/v14i4274

Downloads

Download data is not yet available.

References

Ahmed WS, Geethakumari AM, Biswas KH. Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors. Biomedicine & Pharmacotherapy. 2021;134:111128. DOI: 10.1016/j.biopha.2020.111128

Ren Y, Yuan J, Xue Y, et al. Advanced hydrogels: New expectation for the repair of organic erectile dysfunction. Materials Today Bio. 2023;19:100588. DOI: 10.1016/j.mtbio.2023.100588

Peixoto CA, Nunes AKS, Garcia-Osta A. Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition. Mediators of Inflammation. 2015;2015:1-17. DOI: 10.1155/2015/940207

Swiecicka A. The efficacy of PDE5 inhibitors in diabetic patients. Andrology. 2023;11(2):245-256. DOI: 10.1111/andr.13328

Afsar B, Ortiz A, Covic A, et al. Phosphodiesterase type 5 inhibitors and kidney disease. Int Urol Nephrol. 2015;47 (9):1521-1528. DOI:10.1007/s11255-015-1071-4

Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, Kökény G. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes. Nephrology Dialysis Transplantation. 2013;28(7):1751-1761. DOI: 10.1093/ndt/gfs391

Laties AM. Vision Disorders and Phosphodiesterase Type 5 Inhibitors: A Review of the Evidence to Date. Drug Safety. 2009;32(1):1-18. DOI:10.2165/00002018-200932010-00001

Tsertsvadze A, Fink HA, Yazdi F, et al. Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis. Ann Intern Med. 2009;151 (9):650. DOI: 10.7326/0003-4819-151-9-20091103 0-00150

Bajraktari G, Burhenne J, Bugert P, Haefeli WE, Weiss J. Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets. Biochemical Pharmacology. 2017; 145:54-63.DOI: 10.1016/j.bcp.2017.08.026

Skalicka-Woźniak K, Georgiev MI, Orhan IE. Adulteration of herbal sexual enhancers and slimmers: The wish for better sexual well-being and perfect body can be risky. Food and Chemical Toxicology. 2017;108: 355-364. DOI: 10.1016/j.fct.2016.06.018

Patel DN, Li L, Kee CL, Ge X, Low MY, Koh HL. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: Analytical techniques and challenges. Journal of Pharmaceutical and Biomedical Analysis. 2014;87:176-190. DOI: 10.1016/j.jpba.2013.04.037

Lee JH, Kim NS, Han KM, Kim SH, Cho S, Kim WS. Monitoring by LC-MS/MS of 48 compounds of sildenafil, tadalafil, vardenafil and their analogues in illicit health food products in the Korean market advertised as enhancing male sexual performance. Food Additives & Contaminants: Part A. 2013;30(11):1849-1857. DOI: 10.1080/19440049.2013.826878

Jiru M, Stranska-Zachariasova M, Dzuman Z, et al. Analysis of phosphodiesterase type 5 inhibitors as possible adulterants of botanical-based dietary supplements: extensive survey of preparations available at the Czech market. Journal of Pharmaceutical and Biomedical Analysis. 2019;164:713-724. DOI: 10.1016/j.jpba.2018.11.007

Bujang NB, Chee CF, Heh CH, Rahman NAbd, Buckle MJC. Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014–16. Food Additives & Contaminants: Part A. 2017;34(7):1101-1109. DOI: 10.1080/19440049.2017.1336674

Fejős I, Neumajer G, Béni S, Jankovics P. Qualitative and quantitative analysis of PDE-5 inhibitors in counterfeit medicines and dietary supplements by HPLC–UV using sildenafil as a sole reference. Journal of Pharmaceutical and Biomedical Analysis. 2014;98:327-333. DOI: 10.1016/j.jpba.2014.06.010

Oller-Ruiz A, Campillo N, Fenoll J, Hernández-Córdoba M, Viñas P. Dispersive magnetic solid-phase extraction for synthetic PDE-5 inhibitors determination by high-performance liquid chromatography with tandem mass spectrometry. Advances in Sample Preparation. 2023;7:100071. DOI: 10.1016/j.sampre.2023.100071

Pyo, Jae-Sung, Lee, Hee-Sang, Park, Yu-Jin, et al. Determination of the PDE-5 Inhibitors and Their Analogues by GC-MS and TMS Derivatization. Mass Spectrometry Letters. 2012;3(1):15-17. DOI: 10.5478/MSL.2012.3.1.015

Choi DM, Park S, Yoon TH, et al. Determination of Analogs of Sildenafil and Vardenafil in Foods by Column Liquid Chromatography with a Photodiode Array Detector, Mass Spectrometry, and Nuclear Magnetic Resonance Spectrometry. Journal of AOAC International. 2008;91(3): 580-588. DOI: 10.1093/jaoac/91.3.580

Zhao M, Bergaentzlé M, Flieller A, Marchioni E. Development and validation of an ultra-high performance liquid chromatography-high resolution mass spectrometry method for simultaneous quantification of cyanogenic glycosides and secoisolariciresinol diglucoside in flaxseed (Linum usitatissimum L.). Journal of Chromatography A. 2019;1601:214-223. DOI: 10.1016/j.chroma.2019.04.072

Singh S, Handa T, Narayanam M, Sahu A, Junwal M, Shah RP. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products. Journal of Pharmaceutical and Biomedical Analysis. 2012;69:148-173. DOI: 10.1016/j.jpba.2012.03.044

Ge X, Low MY, Zou P, et al. Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplement. Journal of Pharmaceutical and Biomedical Analysis. 2008;48(4):1070-1075. DOI:10.1016/j.jpba.2008.08.019

Reepmeyer JC, Woodruff JT. Use of liquid chromatography–mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a “natural” herbal dietary supplement. Journal of Chromatography A. 2006;1125 (1):67-75. DOI: 10.1016/j.chroma.2006.05.018

Gratz SR, Gamble BM, Flurer RA. Accurate mass measurement using Fourier transform ion cyclotron resonance mass spectrometry for structure elucidation of designer drug analogs of tadalafil, vardenafil and sildenafil in herbal and pharmaceutical matrices. Rapid Comm Mass Spectrometry. 2006;20(15):2317-2327. DOI: 10.1002/rcm.2594

Mustazza C, Borioni A, Rodomonte AL, et al. Characterization of Sildenafil analogs by MS/MS and NMR: A guidance for detection and structure elucidation of phosphodiesterase-5 inhibitors. Journal of Pharmaceutical and Biomedical Analysis. 2014;96:170-186.Doi: 10.1016/j.jpba.2014.03.038

Görög S. The paradigm shifting role of chromatographic methods in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis. 2012;69:2-8. DOI: 10.1016/j.jpba.2012.01.031

Sacré PY, Deconinck E, Chiap P, et al. Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines. Journal of Chromatography A. 2011;1218(37):6439-6447. DOI: 10.1016/j.chroma.2011.07.029

Lee W, Kim HJ, Lee ME, et al. Reliable screening and classification of phosphodiesterase type 5 inhibitors in dietary supplements using gas chromatography / mass spectrometry combined with specific common ions. Journal of Chromatography A. 2020;1623: 461210. DOI: 10.1016/j.chroma.2020.461210

Kim U, Cho HD, Kang MH, et al. Screening of Phosphodiesterase-5 Inhibitors and Their Analogs in Dietary Supplements by Liquid Chromatography–Hybrid Ion Trap–Time of Flight Mass Spectrometry. Molecules. 2020;25(12):2734. DOI: 10.3390/molecules25122734

Wong JW, Zhang K, Tech K, et al. Multiresidue Pesticide Analysis in Fresh Produce by Capillary Gas Chromatography−MassSpectrometry/Selective Ion Monitoring (GC-MS/SIM) and −Tandem Mass Spectrometry (GC-MS/MS). J Agric Food Chem. 2010;58 (10):5868-5883. DOI: 10.1021/jf903854n

Adaway JE, Keevil BG. Therapeutic drug monitoring and LC–MS/MS. Journal of Chromatography B. 2012;883-884:33-49. DOI: 10.1016/j.jchromb.2011.09.041

Snyder DT, Cooks RG. Single Analyzer Neutral Loss Scans in a Linear Quadrupole Ion Trap Using Orthogonal Double Resonance Excitation. Anal Chem. 2017; 89(15):8148-8155. DOI: 10.1021/acs.analchem.7b01963

Mochizuki T, Shibata K, Naito T, et al. LC-MS/MS method for the quantitation of serum tocilizumab in rheumatoid arthritis patients using rapid tryptic digestion without IgG purification. Journal of Pharmaceutical Analysis. 2022;12(6):852-859. DOI: 10.1016/j.jpha.2022.08.003

Wright MJ, Thomas RL, Stanford PE, Horvath AR. Multiple Reaction Monitoring with Multistage Fragmentation (MRM3) Detection Enhances Selectivity for LC-MS/MS Analysis of Plasma Free Metanephrines. Clinical Chemistry. 2015; 61(3):505-513. DOI: 10.1373/clinchem.2014.233551